Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Gene involved in colorectal cancer also causes breast cancer

Rare mutations in the NTHL1 gene, that were previously associated with colorectal cancer, can also cause breast cancer and other types of cancer. Researchers from Radboud university medical center, LUMC and the Princess Máxima Center, together with international colleagues, describe this new multi-tumor syndrome in the February 11 edition of Cancer Cell. Nicoline Hoogerbrugge, professor of Hereditary Cancer at Radboud university medical center: “We thought all multi-tumor syndromes were known, but we have taken yet another step in identifying cancer genes.”
Hoogerbrugge and colleagues showed previously that mutations in the NTHL1 gene lead to intestinal polyps that may develop into colorectal cancer. However, they observed that patients with a mutation in this gene often have other types of cancer as well. In their publication, the researchers describe 17 families in which members of a single generation had mutations in the NTHL1 gene. Half of these patients developed various types of cancer during their lives, with breast cancer being especially common.
NTHL1
NTHL1 is involved in DNA repair. It recognizes a specific form of DNA damage. If a mutation occurs in the NTHL1 gene, the NTHL1 protein does not work. Consequently, the damage is not recognized and not repaired. This leads to even more unrepaired mutations, which is a cause of cancer. Due to mutations in the NTHL1 gene, errors in the DNA where a ‘C’ is replaced by a ‘T’, are not corrected. This occurs at specific locations in the DNA, resulting in a recognizable mutation pattern.

Mutation pattern

The researchers used a new method to determine that NTHL1 mutations also cause breast cancer and other types of cancer. This method is based on the fact that mutations in the NTHL1 gene cause a specific pattern of other mutations. Because this pattern only occurs in tumors of patients with an NTHL1 mutation, but not in other tumors, the researchers were able to link this pattern to the NTHL1 gene. This method can in future be used to detect new genetic causes of cancer. Roland Kuiper, molecular geneticist at the Princess Máxima Center: “More than 30 such mutation patterns are known, which are not only specific to NTHL1. If all the tumors in a patient with multiple types of cancer have the same mutation pattern, this is a strong indication that a genetic aspect is involved. In that case, all these tumors originated in the same way.”  Recently, Kuiper received a grant from the Dutch cancer society (KWF) to apply this technique in research into pediatric oncology.